Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer. - Wikidata - awgldk - TriplyDB

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

http://www.wikidata.org/entity/Q34374852

about

Carcinogenic effects of "whole-life" exposure to inorganic arsenic in CD1 mice The Interactions of Obesity, Inflammation and Insulin Resistance in Breast Cancer Fucoxanthin and Its Metabolite Fucoxanthinol in Cancer Prevention and Treatment Minireview: Inflammation: an instigator of more aggressive estrogen receptor (ER) positive breast cancers Cyclopia extracts act as ERα antagonists and ERβ agonists, in vitro and in vivo Sustained proliferation in cancer: Mechanisms and novel therapeutic targets ChIP-PED enhances the analysis of ChIP-seq and ChIP-chip data LRP16 integrates into NF-κB transcriptional complex and is required for its functional activation.Palmitoylation: a protein S-acylation with implications for breast cancer.An integrated bioinformatics approach identifies elevated cyclin E2 expression and E2F activity as distinct features of tamoxifen resistant breast tumors.Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.CBP mediates NF-κB-dependent histone acetylation and estrogen receptor recruitment to an estrogen response element in the BIRC3 promoter.The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.Rb inactivation accelerates neoplastic growth and substitutes for recurrent amplification of cIAP1, cIAP2 and Yap1 in sporadic mammary carcinoma associated with p53 deficiency.Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.Estrogen promotes breast cancer cell survival in an inhibitor of apoptosis (IAP)-dependent manner.Negative regulation of NF-κB by the ING4 tumor suppressor in breast cancer δEF1 down-regulates ER-α expression and confers tamoxifen resistance in breast cancer PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres Innate immunity pathways and breast cancer Risk in African American and European-American women in the Women's Circle of Health Study (WCHS).Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.TNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptome Role of NF-κB in the skeleton NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms.Genomic instability influences the transcriptome and proteome in endometrial cancer subtypes.A novel aspirin prodrug inhibits NFκB activity and breast cancer stem cell properties.Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.The scaffold protein MEK Partner 1 is required for the survival of estrogen receptor positive breast cancer cells Prenatal exposure of mice to diethylstilbestrol disrupts T-cell differentiation by regulating Fas/Fas ligand expression through estrogen receptor element and nuclear factor-κB motifs.Estrogen receptor beta as target for colorectal cancer prevention Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis The interaction between ER and NFκB in resistance to endocrine therapy.Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells.Role of nuclear factor-ĸB in breast and colorectal cancer.Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer.Role of Estrogen Response Element in the Human Prolactin Gene: Transcriptional Response and Timing Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway.GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome.

P2860

Q24707869-15C0D9E1-7DB2-40E0-A42C-09FF31C5484E Q26777775-48795A1B-A522-42EA-AB90-4C30910FCD24 Q26799207-3D18C3D2-E44E-4F7F-84AB-5F2868FBAC9D Q27016106-F2A135A1-5D2E-49A3-8738-6EC03A473641 Q27302901-74402241-7420-463C-9CF2-4CE7B2E93A50 Q28396388-56C3AA7E-5E9C-4766-9654-CB04009AB35C Q30596570-1D100343-29D1-4FC5-98DF-0B6A29F7ABD1 Q33869694-C08FC9BA-3EF9-4C94-A2A7-7D2AAE2D1B37 Q33915087-20CD8D04-8A47-4589-AE64-7FB1FCC534DF Q33971409-589AB354-F16E-4F04-819A-6E30237BD4D2 Q34022694-165BF6EB-F50E-4490-A1A6-32989A1B8DB4 Q34029386-BEDC7DCB-8929-435A-A196-364D0D869056 Q34077212-36B19A82-5D80-423B-85BD-EE9233E8CF05 Q34137268-33E59E79-ED41-4C59-B9CD-F44A4DA0E0C5 Q34181200-ED8E16BE-00B5-4EF3-957A-2D7D0BBF5852 Q34259434-D686100B-480E-4089-9DD5-A03ABE5B62DB Q34352011-8C21EEA1-CDB1-4566-A98F-F6939ADCCECF Q34378269-E22C0E17-63FB-4705-A0B8-F84F93D53193 Q34442193-F6AE2DB3-1E90-4915-B3CD-3FFD39169C5B Q34533761-5CB740D4-5CF4-4AB4-89A9-DA8912DEE89B Q34765897-72D09451-C876-45FB-925D-1C19BAD10E6D Q34977106-6C64D1A4-6855-43D3-ADF9-67A9F5136095 Q35097256-20A839DA-E2D0-430D-BF81-234029D64039 Q35269181-F043C28C-B1DD-414B-A730-D2E8FBAD5741 Q35347883-081AED23-9406-458B-8CC0-4B24EAFEB539 Q35469769-F07E8E12-E7E7-4A47-B2C6-F1D45668D744 Q35682449-477B3C24-A9C7-47F5-87DE-FC9B474594BA Q35831031-26AA4059-7389-4B8D-91C6-E7F20B1281A2 Q36050289-5D63556B-6B8C-4E89-ACC9-CF4BC6298798 Q36123118-4A8B3E17-D64A-4142-8594-E4812F208651 Q36335472-05893CF5-C148-4879-A1AB-2B5D74294161 Q36553757-EADB594B-8A00-42C9-A97C-485A945EBBF3 Q36629588-92C1CFA4-EA9C-4C3F-ADAF-08102D5BB45E Q36924406-C6D1CC6D-74F5-4C5B-A6A5-4B6F3CE0367E Q37587494-2E7B83D7-6BDA-415D-8689-28DBB4B0AC55 Q38041500-745ADC95-36D9-4828-B803-7C3FC96EFC98 Q38503758-D31EEB52-A5E0-4AD2-998E-E2EE717C9F92 Q38809955-A2224A84-273B-4C4C-9521-7C97FF8B61E6 Q39001596-AC742318-E48B-4EA9-A668-22861C24F170 Q39798790-49B58399-8938-49DF-AFE2-D5398281670C

P2860

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

http://www.wikidata.org/entity/Q34374852

description

2009 nî lūn-bûn

@nan

2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@ast

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@en

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@nl

type

label

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@ast

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@en

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@nl

prefLabel

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@ast

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@en

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@nl

P1433

Q34374852-04135302-5B6D-4E6B-9372-E2CAAC644324

P1476

Q34374852-76A99EE1-6C4E-4B39-B8B9-6F12D46AEFD8

P2093

Q34374852-B41AD346-0E8E-4DE7-BA7C-5953E545012C

Q34374852-D49EC43C-A3E6-43C9-AA36-D8B502C5D99C

Q34374852-DB347D02-2E70-4073-B5BD-DE0558CBFADA

Q34374852-F37680DA-0EF4-4C86-8F1D-57A8F2BE2305

Q34374852-F4050F83-628A-4346-8882-DB92A0BEC1FE

Q34374852-FEF103F5-8ABB-4AA9-A4EC-34DB890E0BE2

P2860

Q34374852-01940311-2F46-4B1E-ACC0-FA83B140A435

Q34374852-0210A1B0-1534-4406-B9AC-C7E33B1E920D

Q34374852-030A4B00-FAD4-4982-8E76-8D21FFAC4F03

Q34374852-03EF3696-06C3-4EE9-B805-B20AD48CD48C

Q34374852-05C9E3CE-EB5A-46F9-8E47-5BB5816979B2

Q34374852-0AA9435D-ECDF-4E53-82AB-E1587C045891

Q34374852-0EAEC750-3648-47E3-A656-0AD6F238EB63

Q34374852-0F3336D4-1970-4A0C-BDE6-E295EB626A26

Q34374852-144478D1-D4CA-44FB-A91E-F5A952616FA9

Q34374852-1651CF63-2920-4BAC-BAAA-896CE1E70879

P304

Q34374852-4DD4448D-7A76-43A5-8E26-DA0AFDF3058F

P31

Q34374852-B3ABB268-90CB-41D4-9D9D-094A0134E7F6

P356

Q34374852-8719A184-48AB-4B8F-A4B2-6D159224A60A

P407

Q34374852-92F48940-799A-42EA-B365-F769372B4066

P433

Q34374852-2C4C35F2-C88B-4F7A-8893-8E8D5B7E7001

P478

Q34374852-1FBF1195-042C-416B-9A6B-E5834B88802C

P50

Q34374852-0771773A-3F16-4294-922B-A9CD270A00AA

P577

Q34374852-17F3BCA5-FAEB-4CCF-948C-EC7551963619

P5875

Q34374852-5C2D6C5F-5B63-4D19-8CAF-AC9D791346F2

P698

Q34374852-77F89D3B-5C52-45B3-8F4F-C63E4A6B9547

P932

Q34374852-2D17704E-0359-4F6A-9040-338370EAB04B

P356

0008-5472.CAN-09-2608

P1433

Cancer Research

P1476

Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer.

@en

P2093

Adina Stanculescu

http://www.w3.org/2001/XMLSchema#string

Aisha Weaver

http://www.w3.org/2001/XMLSchema#string

Jonna Frasor

http://www.w3.org/2001/XMLSchema#string

Lance D Miller

http://www.w3.org/2001/XMLSchema#string

Madhumita Pradhan

http://www.w3.org/2001/XMLSchema#string

Yang Dai

http://www.w3.org/2001/XMLSchema#string

P2860

CBP Is a dosage-dependent regulator of nuclear factor-kappaB suppression by the estrogen receptor

Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis

The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways

The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

The molecular portraits of breast tumors are conserved across microarray platforms.

P304

8918-8925

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-09-2608

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

38096002

http://www.w3.org/2001/XMLSchema#string

P698

19920189

http://www.w3.org/2001/XMLSchema#string

P932

2996265

http://www.w3.org/2001/XMLSchema#string